VCA Antech (Nasdaq: WOOF) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), VCA Antech met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded. GAAP earnings per share grew significantly.

Margins expanded across the board.

Revenue details
 VCA Antech reported revenue of $465.3 million. The 11 analysts polled by S&P Capital IQ expected revenue of $469.8 million on the same basis. GAAP reported sales were 6.1% higher than the prior-year quarter's $438.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

EPS details
 EPS came in at $0.46. The seven earnings estimates compiled by S&P Capital IQ predicted $0.45 per share. GAAP EPS of $0.46 for Q2 were 18% higher than the prior-year quarter's $0.39 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

Margin details
 For the quarter, gross margin was 24.6%, 160 basis points better than the prior-year quarter. Operating margin was 16.2%, 200 basis points better than the prior-year quarter. Net margin was 9.0%, 120 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $465.2 million. On the bottom line, the average EPS estimate is $0.43.

Next year's average estimate for revenue is $1.82 billion. The average EPS estimate is $1.60.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 232 members out of 246 rating the stock outperform, and 14 members rating it underperform. Among 93 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give VCA Antech a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on VCA Antech is outperform, with an average price target of $28.22.

Is VCA Antech the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.